These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [(11)C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: preclinical characterisation in nonhuman primate. Saba W; Valette H; Peyronneau MA; Bramoullé Y; Coulon C; Curet O; George P; Dollé F; Bottlaender M Synapse; 2010 Jan; 64(1):61-9. PubMed ID: 19728365 [TBL] [Abstract][Full Text] [Related]
5. Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease. Olsen M; Aguilar X; Sehlin D; Fang XT; Antoni G; Erlandsson A; Syvänen S Mol Imaging Biol; 2018 Aug; 20(4):605-614. PubMed ID: 29297157 [TBL] [Abstract][Full Text] [Related]
6. Kinetic modeling of the monoamine oxidase B radioligand [¹¹C]SL25.1188 in human brain with high-resolution positron emission tomography. Rusjan PM; Wilson AA; Miler L; Fan I; Mizrahi R; Houle S; Vasdev N; Meyer JH J Cereb Blood Flow Metab; 2014 May; 34(5):883-9. PubMed ID: 24517979 [TBL] [Abstract][Full Text] [Related]
7. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence. Meyer JH; Wilson AA; Sagrati S; Miler L; Rusjan P; Bloomfield PM; Clark M; Sacher J; Voineskos AN; Houle S Arch Gen Psychiatry; 2009 Dec; 66(12):1304-12. PubMed ID: 19996035 [TBL] [Abstract][Full Text] [Related]
8. Development and Clinical Application of Positron Emission Tomography Imaging Agents for Monoamine Oxidase B. Meyer JH; Braga J Front Neurosci; 2021; 15():773404. PubMed ID: 35280341 [TBL] [Abstract][Full Text] [Related]
9. Radiosynthesis and ex vivo evaluation of [(18)F]-(S)-3-(6-(3-fluoropropoxy)benzo[d]isoxazol-3-yl)-5-(methoxymethyl)oxazolidin-2-one for imaging MAO-B with PET. Hicks JW; Sadovski O; Parkes J; Houle S; Hay BA; Carter RL; Wilson AA; Vasdev N Bioorg Med Chem Lett; 2015 Jan; 25(2):288-91. PubMed ID: 25488845 [TBL] [Abstract][Full Text] [Related]
10. Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Enache D; Pariante CM; Mondelli V Brain Behav Immun; 2019 Oct; 81():24-40. PubMed ID: 31195092 [TBL] [Abstract][Full Text] [Related]
11. [In vivo imaging of astrogliosis by PET]. Harada R; Okamura N Nihon Yakurigaku Zasshi; 2023; 158(1):26-29. PubMed ID: 36596483 [TBL] [Abstract][Full Text] [Related]
13. Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography. Rekkas PV; Wilson AA; Lee VW; Yogalingam P; Sacher J; Rusjan P; Houle S; Stewart DE; Kolla NJ; Kish S; Chiuccariello L; Meyer JH JAMA Psychiatry; 2014 Aug; 71(8):873-9. PubMed ID: 24898155 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and preclinical evaluation of [ Dahl K; Bernard-Gauthier V; Nag S; Varnäs K; Narayanaswami V; Mahdi Moein M; Arakawa R; Vasdev N; Halldin C Bioorg Med Chem Lett; 2019 Jul; 29(13):1624-1627. PubMed ID: 31060887 [TBL] [Abstract][Full Text] [Related]
15. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile. Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694 [TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study. Sacher J; Houle S; Parkes J; Rusjan P; Sagrati S; Wilson AA; Meyer JH J Psychiatry Neurosci; 2011 Nov; 36(6):375-82. PubMed ID: 21463543 [TBL] [Abstract][Full Text] [Related]
17. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Meyer JH; Ginovart N; Boovariwala A; Sagrati S; Hussey D; Garcia A; Young T; Praschak-Rieder N; Wilson AA; Houle S Arch Gen Psychiatry; 2006 Nov; 63(11):1209-16. PubMed ID: 17088501 [TBL] [Abstract][Full Text] [Related]
18. Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635. Sullivan GM; Ogden RT; Huang YY; Oquendo MA; Mann JJ; Parsey RV Depress Anxiety; 2013 Mar; 30(3):197-206. PubMed ID: 23408467 [TBL] [Abstract][Full Text] [Related]
19. Association of ventral striatum monoamine oxidase-A binding and functional connectivity in antisocial personality disorder with high impulsivity: A positron emission tomography and functional magnetic resonance imaging study. Kolla NJ; Dunlop K; Downar J; Links P; Bagby RM; Wilson AA; Houle S; Rasquinha F; Simpson AI; Meyer JH Eur Neuropsychopharmacol; 2016 Apr; 26(4):777-86. PubMed ID: 26908392 [TBL] [Abstract][Full Text] [Related]
20. Lower Monoamine Oxidase-A Total Distribution Volume in Impulsive and Violent Male Offenders with Antisocial Personality Disorder and High Psychopathic Traits: An [(11)C] Harmine Positron Emission Tomography Study. Kolla NJ; Matthews B; Wilson AA; Houle S; Bagby RM; Links P; Simpson AI; Hussain A; Meyer JH Neuropsychopharmacology; 2015 Oct; 40(11):2596-603. PubMed ID: 26081301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]